{
    "code": "02025728",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025728",
    "time": "2019-12-20 03:37:35",
    "許可證字號": "衛署藥輸字第025728號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/06\/14",
    "發證日期": "101\/06\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202572802",
    "中文品名": "&quot;百博&quot;愛諾康靜脈輸注濃縮液20毫克\/毫升",
    "英文品名": "Irinotecan BioPro 20mg\/ml, concentrate for solution for infusion",
    "適應症": "晚期性大腸癌之第一線治療藥物、與5-FU及FOLINIC ACID合併，使用於未曾接受過化學治療之化療之患者、單獨使用於曾接受5-FU療程治療無效之患者。",
    "劑型": "270注射劑",
    "包裝": "2毫升,5毫升,25毫升玻璃小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 24監視期滿學名藥",
        "申請商名稱": "620102Q259  百博生技有限公司",
        "申請商地址": "台北市大安區信義路4段6號15樓之4",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037710",
            "成分名稱": "IRINOTECAN HYDROCHLORIDE TRIHYDRATE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "02025728-108-10-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025728&Seq=003&Type=9"
        },
        {
            "title": "愛諾康 Irinotecan_外盒-106-01-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025728&Seq=003&Type=8"
        }
    ]
}